GIA
TEVA icon

Gladstone Institutional Advisory’s Teva Pharmaceuticals TEVA Stock Holding History

Gladstone Institutional Advisory’s Portfolio TEVA Stock Details TEVA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$395K Hold
11,672
– – 0.01% 663
2026
Q1 		$352K Sell
11,672
-54
-0.5% -$1.74K 0.01% 626
2025
Q4 		$366K Sell
11,726
-5,846
-33% -$144K 0.01% 579
2025
Q3 		$355K Buy
17,572
+4,635
+36% +$81.4K 0.01% 598
2025
Q2 		$217K Sell
12,937
-1,935
-13% -$31.2K 0.01% 694
2025
Q1 		$229K Sell
14,872
-139,377
-90% -$2.49M 0.01% 653
2024
Q4 		$3.4M Buy
154,249
+10,310
+7% +$188K 0.16% 154
2024
Q3 		$2.59M Buy
143,939
+128,748
+848% +$2.25M 0.13% 185
2024
Q2 		$247K Sell
15,191
-150
-1% -$2.31K 0.01% 579
2024
Q1 		$216K Buy
15,341
+1,180
+8% +$14.9K 0.01% 592
2023
Q4 		$148K Buy
14,161
+575
+4% +$5.37K 0.01% 636
2023
Q3 		$139K Hold
13,586
– – 0.01% 588
2023
Q2 		$102K Hold
13,586
– – 0.01% 612
2023
Q1 		$120K Sell
13,586
-989
-7% -$9.78K 0.01% 628
2022
Q4 		$133K Hold
14,575
– – 0.01% 614
2022
Q3 		$118K Hold
14,575
– – 0.01% 606
2022
Q2 		$110K Sell
14,575
-128
-0.9% -$1.11K 0.01% 620
2022
Q1 		$138K Buy
+14,703
New +$123K 0.01% 677

Other funds holding TEVA

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
HIIFS
Harel Insurance Investments & Financial Services Ramat Gan, Israel $20.6B AUM 59.59% 1-Year Est. Return
PF
Phoenix Financial Givatayim, Israel $14.6B AUM 57.48% 1-Year Est. Return
WCM Investment Management
WCM Investment Management Laguna Beach, California $55.2B AUM 57.07% 1-Year Est. Return
CI
Clal Insurance Tel-Aviv, Israel $22.3B AUM 79.91% 1-Year Est. Return
MMH
Menora Mivtachim Holdings Ramat Gan, Israel $25.6B AUM 50.04% 1-Year Est. Return
MIFH
Migdal Insurance & Financial Holdings Petach Tikva, Israel $15.6B AUM 71.29% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
LIM
Lingotto Investment Management London, United Kingdom $4.67B AUM 70.24% 1-Year Est. Return

Gladstone Institutional Advisory's TEVA Position: Q2 2026 in Review

Gladstone Institutional Advisory held its Teva Pharmaceuticals (TEVA) position steady in Q2 2026 at 11,672 shares worth $395K. The position accounts for 0.01% of the portfolio, ranked #663.

Gladstone Institutional Advisory first reported a position in TEVA in Q1 2022 and has held it in 18 quarters since. The position peaked at $3.4M in Q4 2024. 673 funds tracked by Wall St. Rank hold TEVA as of Q2 2026.

  • Gladstone Institutional Advisory held 11,672 shares of Teva Pharmaceuticals worth $395K as of Q2 2026.
  • Gladstone Institutional Advisory left its Teva Pharmaceuticals share count unchanged in Q2 2026.
  • Teva Pharmaceuticals made up 0.01% of Gladstone Institutional Advisory's portfolio in Q2 2026, its #663 holding.
  • Gladstone Institutional Advisory first reported a position in Teva Pharmaceuticals in Q1 2022 and has held it in 18 quarters since.
  • Gladstone Institutional Advisory's Teva Pharmaceuticals position peaked at $3.4M in Q4 2024.
  • 673 funds tracked by Wall St. Rank held Teva Pharmaceuticals as of Q2 2026.

Based on Gladstone Institutional Advisory's 13F filing for Q2 2026, filed 27 Jul 2026.